The immune system in neurological diseases: What innate-like T cells have to say
The immune system classically consists of 2 lines of defense, innate and adaptive, both of which interact with one another effectively to protect us against any pathogenic threats. Importantly, there is a diverse subset of cells known as innate-like T cells that act as a bridge between the innate an...
Gespeichert in:
Veröffentlicht in: | Journal of allergy and clinical immunology 2024-04, Vol.153 (4), p.913-923 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 923 |
---|---|
container_issue | 4 |
container_start_page | 913 |
container_title | Journal of allergy and clinical immunology |
container_volume | 153 |
creator | Wyatt-Johnson, Season K. Afify, Reham Brutkiewicz, Randy R. |
description | The immune system classically consists of 2 lines of defense, innate and adaptive, both of which interact with one another effectively to protect us against any pathogenic threats. Importantly, there is a diverse subset of cells known as innate-like T cells that act as a bridge between the innate and adaptive immune systems and are pivotal players in eliciting inflammatory immune responses. A growing body of evidence has demonstrated the regulatory impact of these innate-like T cells in central nervous system (CNS) diseases and that such immune cells can traffic into the brain in multiple pathological conditions, which can be typically attributed to the breakdown of the blood-brain barrier. However, until now, it has been poorly understood whether innate-like T cells have direct protective or causative properties, particularly in CNS diseases. Therefore, in this review, our attention is focused on discussing the critical roles of 3 unique subsets of unconventional T cells, namely, natural killer T cells, γδ T cells, and mucosal-associated invariant T cells, in the context of CNS diseases, disorders, and injuries and how the interplay of these immune cells modulates CNS pathology, in an attempt to gain a better understanding of their complex functions. |
doi_str_mv | 10.1016/j.jaci.2024.02.003 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2928246370</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S009167492400157X</els_id><sourcerecordid>2928246370</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-3832a211235ba33d8ab35e6771080892f137cbafad467ed9d620abaac504d61c3</originalsourceid><addsrcrecordid>eNp9kEtPwzAQhC0EoqXwBzggH7kkrO3ESRAXVPGSkOBQxNHa2FvqkgfECVL_PakKHDmtVjszmv0YOxUQCxD6Yh2v0fpYgkxikDGA2mNTAUUW6Vym-2wKUIhIZ0kxYUchrGHcVV4csonKlU5BpFP2vFgR93U9NMTDJvRUc9_whoaurdo3b7HizgfCQOGSv66wH88N9hRV_p34gluqqsBX-EW8b3nAzTE7WGIV6ORnztjL7c1ifh89Pt09zK8fI6sg66OxgUQphFRpiUq5HEuVks4yATnkhVwKldkSl-gSnZErnJaAJaJNIXFaWDVj57vcj679HCj0pvZh2wYbaodgZCFzmWiVwSiVO6nt2hA6WpqPztfYbYwAsyVp1mZL0mxJGpBmJDmazn7yh7Im92f5RTcKrnYCGr_88tSZYD01lpzvyPbGtf6__G9ugYOr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2928246370</pqid></control><display><type>article</type><title>The immune system in neurological diseases: What innate-like T cells have to say</title><source>Access via ScienceDirect (Elsevier)</source><creator>Wyatt-Johnson, Season K. ; Afify, Reham ; Brutkiewicz, Randy R.</creator><creatorcontrib>Wyatt-Johnson, Season K. ; Afify, Reham ; Brutkiewicz, Randy R.</creatorcontrib><description>The immune system classically consists of 2 lines of defense, innate and adaptive, both of which interact with one another effectively to protect us against any pathogenic threats. Importantly, there is a diverse subset of cells known as innate-like T cells that act as a bridge between the innate and adaptive immune systems and are pivotal players in eliciting inflammatory immune responses. A growing body of evidence has demonstrated the regulatory impact of these innate-like T cells in central nervous system (CNS) diseases and that such immune cells can traffic into the brain in multiple pathological conditions, which can be typically attributed to the breakdown of the blood-brain barrier. However, until now, it has been poorly understood whether innate-like T cells have direct protective or causative properties, particularly in CNS diseases. Therefore, in this review, our attention is focused on discussing the critical roles of 3 unique subsets of unconventional T cells, namely, natural killer T cells, γδ T cells, and mucosal-associated invariant T cells, in the context of CNS diseases, disorders, and injuries and how the interplay of these immune cells modulates CNS pathology, in an attempt to gain a better understanding of their complex functions.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2024.02.003</identifier><identifier>PMID: 38365015</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>CD1d ; CNS diseases ; MAIT cells ; MR1 ; neuroimmunology ; neuroinflammation ; NKT cells ; γδ T cells</subject><ispartof>Journal of allergy and clinical immunology, 2024-04, Vol.153 (4), p.913-923</ispartof><rights>2024 American Academy of Allergy, Asthma & Immunology</rights><rights>Copyright © 2024. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c307t-3832a211235ba33d8ab35e6771080892f137cbafad467ed9d620abaac504d61c3</cites><orcidid>0000-0002-7396-480X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2024.02.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38365015$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wyatt-Johnson, Season K.</creatorcontrib><creatorcontrib>Afify, Reham</creatorcontrib><creatorcontrib>Brutkiewicz, Randy R.</creatorcontrib><title>The immune system in neurological diseases: What innate-like T cells have to say</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>The immune system classically consists of 2 lines of defense, innate and adaptive, both of which interact with one another effectively to protect us against any pathogenic threats. Importantly, there is a diverse subset of cells known as innate-like T cells that act as a bridge between the innate and adaptive immune systems and are pivotal players in eliciting inflammatory immune responses. A growing body of evidence has demonstrated the regulatory impact of these innate-like T cells in central nervous system (CNS) diseases and that such immune cells can traffic into the brain in multiple pathological conditions, which can be typically attributed to the breakdown of the blood-brain barrier. However, until now, it has been poorly understood whether innate-like T cells have direct protective or causative properties, particularly in CNS diseases. Therefore, in this review, our attention is focused on discussing the critical roles of 3 unique subsets of unconventional T cells, namely, natural killer T cells, γδ T cells, and mucosal-associated invariant T cells, in the context of CNS diseases, disorders, and injuries and how the interplay of these immune cells modulates CNS pathology, in an attempt to gain a better understanding of their complex functions.</description><subject>CD1d</subject><subject>CNS diseases</subject><subject>MAIT cells</subject><subject>MR1</subject><subject>neuroimmunology</subject><subject>neuroinflammation</subject><subject>NKT cells</subject><subject>γδ T cells</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPwzAQhC0EoqXwBzggH7kkrO3ESRAXVPGSkOBQxNHa2FvqkgfECVL_PakKHDmtVjszmv0YOxUQCxD6Yh2v0fpYgkxikDGA2mNTAUUW6Vym-2wKUIhIZ0kxYUchrGHcVV4csonKlU5BpFP2vFgR93U9NMTDJvRUc9_whoaurdo3b7HizgfCQOGSv66wH88N9hRV_p34gluqqsBX-EW8b3nAzTE7WGIV6ORnztjL7c1ifh89Pt09zK8fI6sg66OxgUQphFRpiUq5HEuVks4yATnkhVwKldkSl-gSnZErnJaAJaJNIXFaWDVj57vcj679HCj0pvZh2wYbaodgZCFzmWiVwSiVO6nt2hA6WpqPztfYbYwAsyVp1mZL0mxJGpBmJDmazn7yh7Im92f5RTcKrnYCGr_88tSZYD01lpzvyPbGtf6__G9ugYOr</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Wyatt-Johnson, Season K.</creator><creator>Afify, Reham</creator><creator>Brutkiewicz, Randy R.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7396-480X</orcidid></search><sort><creationdate>20240401</creationdate><title>The immune system in neurological diseases: What innate-like T cells have to say</title><author>Wyatt-Johnson, Season K. ; Afify, Reham ; Brutkiewicz, Randy R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-3832a211235ba33d8ab35e6771080892f137cbafad467ed9d620abaac504d61c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CD1d</topic><topic>CNS diseases</topic><topic>MAIT cells</topic><topic>MR1</topic><topic>neuroimmunology</topic><topic>neuroinflammation</topic><topic>NKT cells</topic><topic>γδ T cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wyatt-Johnson, Season K.</creatorcontrib><creatorcontrib>Afify, Reham</creatorcontrib><creatorcontrib>Brutkiewicz, Randy R.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wyatt-Johnson, Season K.</au><au>Afify, Reham</au><au>Brutkiewicz, Randy R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The immune system in neurological diseases: What innate-like T cells have to say</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>153</volume><issue>4</issue><spage>913</spage><epage>923</epage><pages>913-923</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>The immune system classically consists of 2 lines of defense, innate and adaptive, both of which interact with one another effectively to protect us against any pathogenic threats. Importantly, there is a diverse subset of cells known as innate-like T cells that act as a bridge between the innate and adaptive immune systems and are pivotal players in eliciting inflammatory immune responses. A growing body of evidence has demonstrated the regulatory impact of these innate-like T cells in central nervous system (CNS) diseases and that such immune cells can traffic into the brain in multiple pathological conditions, which can be typically attributed to the breakdown of the blood-brain barrier. However, until now, it has been poorly understood whether innate-like T cells have direct protective or causative properties, particularly in CNS diseases. Therefore, in this review, our attention is focused on discussing the critical roles of 3 unique subsets of unconventional T cells, namely, natural killer T cells, γδ T cells, and mucosal-associated invariant T cells, in the context of CNS diseases, disorders, and injuries and how the interplay of these immune cells modulates CNS pathology, in an attempt to gain a better understanding of their complex functions.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38365015</pmid><doi>10.1016/j.jaci.2024.02.003</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-7396-480X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-6749 |
ispartof | Journal of allergy and clinical immunology, 2024-04, Vol.153 (4), p.913-923 |
issn | 0091-6749 1097-6825 |
language | eng |
recordid | cdi_proquest_miscellaneous_2928246370 |
source | Access via ScienceDirect (Elsevier) |
subjects | CD1d CNS diseases MAIT cells MR1 neuroimmunology neuroinflammation NKT cells γδ T cells |
title | The immune system in neurological diseases: What innate-like T cells have to say |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T23%3A09%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20immune%20system%20in%20neurological%20diseases:%20What%20innate-like%20T%20cells%20have%20to%20say&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Wyatt-Johnson,%20Season%20K.&rft.date=2024-04-01&rft.volume=153&rft.issue=4&rft.spage=913&rft.epage=923&rft.pages=913-923&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2024.02.003&rft_dat=%3Cproquest_cross%3E2928246370%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2928246370&rft_id=info:pmid/38365015&rft_els_id=S009167492400157X&rfr_iscdi=true |